Evidence map›Paper›PMID 33280262›Full record

ArticleCancer medicine2021

Lidocaine inhibits the metastatic potential of ovarian cancer by blocking Na

Chang Liu, Ming Yu, Yi Li, Hao Wang, Chuanya Xu, Xiaoqing Zhang, Min Li, Hongyan Guo, Daqing Ma, Xiangyang Guo

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework-8 Nanoparticles.Chemphyschem : a European journal of chemical physics and physical chemistry · 2025
    Article
  11. Review
  12. Review
  13. Effects of NaCell biochemistry and biophysics · 2025
    Review
  14. Article
  15. Article
  16. Opioid System and Epithelial-Mesenchymal Transition.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  17. Effects of anesthetics on development of gynecological cancer.Frontiers in cell and developmental biology · 2025
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Chang LiuDepartment of Anesthesiology, Peking University Third Hospital, Beijing, China.
Ming YuDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China.
Yi LiDepartment of Anesthesiology, Peking University Third Hospital, Beijing, China.
Hao WangDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China.
Chuanya XuDepartment of Anesthesiology, Peking University Third Hospital, Beijing, China.
Xiaoqing ZhangDepartment of Anesthesiology, Peking University Third Hospital, Beijing, China.
Min LiDepartment of Anesthesiology, Peking University Third Hospital, Beijing, China.
Hongyan GuoDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Daqing MaAnaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom.ORCID 0000-0003-1235-0537
Xiangyang GuoDepartment of Anesthesiology, Peking University Third Hospital, Beijing, China.
Peking University · CNDalian Medical University · CNChelsea and Westminster Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lidocaine, one of the most commonly used local anesthetics during surgery, has been reported to suppress cancer cell growth via blocking voltage-gated sodium channels (VGSCs). VGSC 1.5 (Na

Indexed as

AnimalsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsCell Line, TumorCell MovementCisplatinEpithelial-Mesenchymal TransitionFemaleFocal Adhesion Kinase 1HumansLidocaineMiceMice, Inbred C57BLNAV1.5 Voltage-Gated Sodium ChannelNeoplasm MetastasisOvarian NeoplasmsAntineoplastic AgentsCisplatinFocal Adhesion Kinase 1LidocaineNAV1.5 Voltage-Gated Sodium ChannelPaxillinPTK2 protein, humanPXN protein, humanSCN5A protein, humanVoltage-Gated Sodium Channel BlockerscisplatinlidocainemetastasisNaV1.5ovarian cancer

Identifiers

PMID33280262
PMCPMC7826465
OpenAlexW3112640871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.